MTS Assay Kit (Cell Proliferation) (Colorimetric) (ab197010)
Key features and details
- Assay type: Quantitative
- Detection method: Colorimetric
- Platform: Microplate reader
- Assay time: 4 hr
- Sample type: Adherent cells, Suspension cells
Overview
-
Product name
MTS Assay Kit (Cell Proliferation) (Colorimetric)
See all Cell viability/proliferation kits -
Detection method
Colorimetric -
Sample type
Adherent cells, Suspension cells -
Assay type
Quantitative -
Assay time
4h 00m -
Product overview
MTS Assay Kit ab197010 uses a colorimetric method for the sensitive quantification of viable cells. It is based on a single ready-to-use reagent. The MTS assay is used to assess cell proliferation, cell viability and cytotoxicity.
The MTS assay protocol is based on the reduction of the MTS tetrazolium compound by viable mammalian cells (and cells from other species) to generate a colored formazan dye that is soluble in cell culture media. This conversion is thought to be carried out by NAD(P)H-dependent dehydrogenase enzymes in metabolically active cells. The formazan dye is quantified by measuring the absorbance at 490-500 nm. NB: MTS is also available as free molecule as ab223881 (Tetrazolium inner salt cell proliferation reagent).
MTS assay protocol summary:
- add MTS reagent to cell culture media
- incubate for 0.5 - 4 hours in standard culture conditions
- shake plate briefly and measure absorbance at 490 nm.
The MTS assay is suitable for standard cell culture plates or 96-well and other microtitre well plates.
MTS assays are often used for the measurement of cell proliferation in response to growth factors, cytokines, mitogens, and nutrients, etc. They are also used for the analysis of cytotoxic compounds like anticancer drugs and other toxic agents.
-
Notes
This product is manufactured by BioVision, an Abcam company and was previously called K300 MTS Cell Proliferation Colorimetric Assay Kit. K300-2500 is the same size as the 2500 test size of ab197010.
Review our cell health assay guide to learn about kits to perform a cell viability assay, cytotoxicity assay or cell proliferation assay.
How other researchers have used MTS Assay Kit ab197010
The MTS assay kit has been used in publications with a variety of cell lines and primary cells, including:
FB671 fibroblasts1, HUVEC and 4T1 cells2, IBRS-2 pig kidney cells3, mouse mesangial kidney cells4, human pancreatic ductal adenocarcinoma (PANC-1) and normal dermal fibroblast 3D co-cultures5, human primary fibroblasts6, human HuccT1 cholangiocarcinoma cells7, human glioma cell line8, human embryonic kidney cell line9, human 97L liver cancer cell line10, canine and human PBMCs11References: 1-Seminotti B et al 2019, 2-Amirshaghaghi A et al 2019, 3-Li SF et al 2019, 4-Widowati W et al 2018, 5-Betriu N and Semino CE 2018, 6-Leipnitz G et al 2018, 7-Lin HY et al 2018, 8-Nadaradjane A et al 2018, 9-Broguiere et al 2018, 10-Zhang K et al 2018, 11-Gardin C et al 2018
-
Platform
Microplate reader
Properties
-
Storage instructions
Store at -20°C. Please refer to protocols. -
Components 500 tests 2500 tests 250 tests 5000 tests 10000 tests MTS Reagent 1 x 10ml 1 x 50ml 1 x 5ml 1 x 100ml 1 x 200ml -
Research areas
-
Relevance
Cell proliferation is the multiplication or reproduction of cells, as a result of cell growth and cell division, resulting in the expansion of a cell population. -
Alternative names
- Cell Cytotoxicity
- cell tracking
Associated products
-
Related Products
Images
-
Absorbance at OD=490 nm is proportional to cell density
Jurkat cells were cultured at different densities overnight at 37°C in a final volume of 200 µL/well. MTS reagent was added and absorbance at OD=490 nm was recorded using ELISA plate reader. Each point represents a mean of 3 replicates. Assay was performed according to the kit protocol.
-
Viability of 4T1 cells using MTS assayAmirshaghaghi A et al. Sci Rep. 2019; 9: 2613. doi: 10.1038/s41598-019-39036-1. Reproduced under the creative commons license http://creativecommons.org/licenses/by/4.0/.Amirshaghaghi A et al. used MTS assay kit ab197010 in their study of a new preparation of the Chlorin e6 photosensitizer (Ce6). Ce6 is used in photodynamic tumor therapy: photosensitizers localized to tumor cells produce cytotoxic reactive oxygen species on exposure to specific wavelengths of light.
They used the MTS assay kit to measure the viability of 4T1 cells treated with different concentrations of their Ce6 preparation, with and without laser irradiation (665 nm, 5 J/cm2).
-
Fibroblast Cell Viability MTS AssayLeipnitz G et al. Sci Rep. 2018; 8: 1165. doi: 10.1038/s41598-018-19543-3 Reproduced under the creative commons license http://creativecommons.org/licenses/by/4.0/.Leipnitz G et al. used MTS assay kit ab197010 in their study of mitochondrial complex I deficiency.
They used the MTS assay to examine the reduction in the cell viability of ND6 deficient and ACAD9 deficient fibroblasts, compared to wild type, when cultured in the absence and presence of glucose.
-
Hepatocyte Cell Viability studied with MTS assayCabrera D et al. Sci Rep. 2017; 7: 3491. doi: 10.1038/s41598-017-03675-z. Reproduced under the creative commons license http://creativecommons.org/licenses/by/4.0/.Cabrera et al. used MTS assay kit ab197010 as part of studying ANDRO (Andrographolide), an anti-inflammatory compound with potential for use in the treatment of nonalcoholic steatohepatitis.They used the MTS assay to demonstrate that ANDRO did not affect cell viability at the concentrations used in their study.
Datasheets and documents
-
Datasheet download
References (80)
ab197010 has been referenced in 80 publications.
- Li P et al. Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells. Carcinogenesis 42:136-147 (2021). PubMed: 32710611
- Corominas J et al. Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma. Cancers (Basel) 13:N/A (2021). PubMed: 33498698
- Su W et al. Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer. J Exp Clin Cancer Res 40:88 (2021). PubMed: 33648545
- Deng Y et al. Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis. Oncol Lett 21:344 (2021). PubMed: 33747201
- Guo F et al. NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15. Cell Death Discov 7:78 (2021). PubMed: 33850096
